drugset
drugset / Trial / NCT01093118

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

NCT01093118 ↗

Phase 2 Terminated 120 enrolled Talima Therapeutics, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).

Timeline

Start
2009-09
Primary completion
2011-04
Completion
—

Outcome

Outcome not reported

Stopped (Business): “Business decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject TMI-358 Unknown — Other

Indications

tinea unguium